Related studies have also found that UHRF1 is highly expressed in breast cancer, bladder cancer, prostate cancer, and CRC (Jenkins et al., 2005; Zhu et al., 2015; Wan et al., 2016; Saidi et al., 2017). Here, UHRF1 is linked to breast carcinoma.